PlumCare, an Alameda, CA-based DNA advisory service for families, secured an additional $750k in seed funding.
The round was led by Steuart Ventures.
The company will use the funds to further support commercialization and access to its proprietary tests and services.
Led by Petros Tsipouras, M.D., CEO and co-founder, PlumCare Created by clinical geneticists, Dr. Paul Billings and Dr. Petros Tsipouras, PlumCare DNA Advisor provides families with access to genetics through DNA testing, analysis, insights to manage unexpected or chronic illnesses and their well-being across generations for a lifetime.
The service combines saliva-based whole exome DNA testing, data from all participating family members (family trios or more), family medical history, external research and analysis.
With a subscription, the service provides ongoing monitoring of scientific advances with annual reports and notifications.
In addition to the funding, the company has also reached a partnership agreement with Cordlife Group Limited, a Singapore Exchange mainboard listed consumer healthcare company, as it expands access to the first-ever lifetime DNA testing and advisory service for families.